Brainsway gets approval for smoking cessation study

The firm's Deep TMS device is a noninvasive technique used to apply brief magnetic pulses to the brain.

Brainsway Ltd. (TASE:BRIN) said today that it has received Ministry of Health approval for a clinical trial at the Be'er Ya'akov Mental Health Center. The clinical trial will study the effectiveness of Brainsway's Deep TMS device in helping chronic lung disease patients quit smoking.

Deep TMS (transcranial magnetic stimulation) is a noninvasive technique used to apply brief magnetic pulses to the brain. Brainsway is testing the technology in treating various psychological and neurological conditions, such as schizophrenia, depression, and Alzheimer's disease.

The new Be'er Ya'akov study will follow 90-102 patients.

Shares in Brainsway rose 2.37% to NIS 13.41 on the Tel Aviv Stock Exchange (TASE) today.

Published by Globes [online], Israel business news - - on June 29, 2009

© Copyright of Globes Publisher Itonut (1983) Ltd. 2009

View comments in rows
Update by email about comments talkback
Your name
Please insert your name
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Joseph Papa Perrigo up for sale

The pharmaceutical firm is seeking a merger at a premium on its $20 billion market cap.

Twitter Facebook Linkedin RSS Newsletters גלובס